1. Introduction
1.1. Market Scope and Segmental Definition
1.2. Assumptions & Limitation
2. Research Methodology
2.1. Research Approach & Data Sources
2.2. Forecasting Model
3. Executive Summary
3.1. Analyst?s Insights
3.2. Top Line Market estimation
3.3. Value Chain Analysis
4. Market Forces
4.1. Key Industry Drivers, Restraints and Opportunities
4.2. Industry Trends
5. Market Outlook by Product Category (Current size & future market estimates)
5.1. Instruments
5.2. Consumables
5.3. Software & Services
6. Market Outlook by Technology (Current size & future market estimates)
6.1. Comparative Genomic Hybridization
6.1.1. Array-Based Comparative
Genomic Hybridization
6.1.2. Standard Comparative Genomic Hybridization
6.2. Fluorescence in Situ
Hybridization
6.3. Immunohistochemistry
6.4. Karyotyping
6.4.1. Spectral karyotyping
6.4.2. Virtual karyotyping
6.5. Others
7. Market Outlook by Applications (Current size & future market estimates)
7.1.Genetic Disorders
7.2. Oncology
7.3. Personalized Medicine
7.4. Other applications
8. Market Outlook by End-use (Current size & future market estimates)
8.1. Clinical & Research Laboratories
8.2. Hospitals & Pathology Laboratories
8.3. Academic Research Institutes
8.4. Pharmaceutical and Biotechnology Companies
8.5. Other end-use
9. Market Outlook by Regions (Current size & future market estimates)
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. U.K.
9.2.2. Germany
9.3. APAC
9.3.1. China
9.3.2. Japan
9.4. Latin America
9.4.1. Brazil
9.5. MEA
9.5.1. South Africa
10. Competitive Landscape
10.1. Market Share/Market Ranking Analysis
10.2. Competitive Market Scenario (New Product Innovations, Key Strategic Moves & Partnerships, Start-ups Ecosystem)
11. Company Profiles
Includes: Company Overview, Product & Services Offerings, Financials (only for listed companies), New Developments and Innovation)
11.1. BIOVIEW
11.2. Danaher
11.3. MetaSystems
11.4. Agilent Technologies, Inc.
11.5. Abbott
11.6. Bio-Rad Laboratories, Inc.
11.7. Illumina, Inc.
11.8. Oxford Gene Technology
11.9. F. Hoffmann-La Roche Ltd
11.10. PerkinElmer Inc.
